Form D · Other Health Care
Recombinant Diagnostics LLC
Aventura, FL · CIK 0002141501
Offering snapshot reported Jun 30, 2026 · SEC filing
- Reported sold
- $150K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 16, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Initial | $150,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589033
Source: Form D, filed Jun 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Recombinant Mgmt Llc | Executive |
| William Charles Tanenbaum | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
19505 Biscayne Blvd, Suite 2350
Aventura, FL, 33180
Aventura, FL, 33180